Institutional Ownership

IMMUNOMEDICS (IMMU) Institutional Ownership & Top Holders

The most recent SEC Form 13F filings (Q3 2020) show 10 hedge funds and institutional investors holding a combined 34.9M shares of IMMUNOMEDICS (IMMU), valued at $3.0B. The median portfolio weight is 4.1%.

Quarterly institutional ownership changes in IMMU show net buying, with the combined position increasing by 3.8M shares (12.2%) from the previous quarter.

Among 13F filers, the funds with the highest portfolio allocation to IMMU are Avoro Capital Advisors (31.7% of its 13F portfolio), Sand Grove Capital Management (21.2%), and Melqart (7.6%). In Q3 2020, Sand Grove Capital Management made the largest position increase (+21.2%), while Avidity made the largest reduction (-4.3%).

Top 10 Institutional Holders in IMMUNOMEDICS (IMMU), Ranked by Portfolio Weight

Based on the latest SEC Form 13F filings (Q3 2020).

# Fund Shares Market Value Portfolio Weight
1 Avoro Capital Advisors 26,250,000 $2.2B 31.7%
2 Sand Grove Capital Management 470,000 $40.0M 21.2%
3 Melqart 800,000 $68.0M 7.6%
4 Pentwater Capital Management 3,920,000 $333.3M 6.8%
5 Deerfield 2,304,900 $196.0M 4.8%
6 Glazer Capital 842,704 $71.7M 3.5%
7 Baker Bros. Advisors 237,694 $20.2M 0.1%
8 Chescapmanager 3,830 $326K 0.1%
9 Fairfax Financial Holdings 8,500 $722K 0.0%
10 Maverick Capital 12,967 $1.1M 0.0%
Latest
  • 10
    Institutional investors
  • 34,850,595
    Shares held (disclosed)
  • $3.0B
    13F market value
  • 4.1%
    Median portfolio weight

Ownership History

Quarter-by-quarter share count, market value, and portfolio conviction weight (up to 5 of the heaviest weight-by-portfolio funds) of IMMU. Sourced from 13F filings; reflects long equity positions only.

Quarter-over-Quarter ActivityQ3 2020

The biggest weight-increase and weight-decrease changes among funds that hold IMMU. Deltas compare the selected filing to the previous reporting quarter.

Top buyers

Top sellers

Ownership Statistics

Funds holding
10
Median weight
4.1%
Largest holder
Avoro Capital Advisors · 31.7%
Smallest holder
Maverick Capital · 0.0%
Shares held
34,850,595 (+3,798,295)

All Institutional HoldersSortable · searchable

All institutional investors (Max 50) holding IMMU in the selected quarter. Click a fund name to drill into its full 13F portfolio.

10 of 10 institutional investors
1Avoro Capital Advisors26,250,000$2.2B31.7%
2Sand Grove Capital Management470,000$40.0M21.2%
3Melqart800,000$68.0M7.6%
4Pentwater Capital Management3,920,000$333.3M6.8%
5Deerfield2,304,900$196.0M4.8%
6Glazer Capital842,704$71.7M3.5%
7Baker Bros. Advisors237,694$20.2M0.1%
8Chescapmanager3,830$326.0K0.1%
9Fairfax Financial Holdings8,500$722.0K0.0%
10Maverick Capital12,967$1.1M0.0%

Institutional Investor Count Over Time

Number of institutional investors disclosing a long position in IMMUNOMEDICS INC (IMMU) each reporting quarter. Sourced from SEC Form 13F-HR filings.

Methodology & FAQ

Methodology: How We Track IMMU Institutional Holdings

Our data is systematically aggregated directly from quarterly Form 13F-HR disclosures submitted to the U.S. Securities and Exchange Commission (SEC).

  • Who Must File (Reporting Threshold): This dataset includes filings from U.S. institutional investment managers, hedge funds, mutual funds, university endowments, and family offices managing at least $100 million in Section 13(f) securities (including equities, options, convertibles, ETFs, and warrants).
  • What is Included (Data Scope): We capture long positions in Section 13(f) securities for IMMUNOMEDICS INC (IMMU). By SEC regulation, 13F filings do not require the disclosure of short positions, non-U.S. holdings, or OTC derivatives. Listed options are excluded from portfolio weight calculations to ensure comparability across filers.
  • Portfolio Weight Explained (Metric Definition): “Portfolio Weight” shows how much of a fund's total reported 13F portfolio value (excluding listed options) is allocated to IMMU on the specific reporting date.
  • How to Use This Data (Interpretation): Quarter-over-quarter changes in shares and portfolio weight reflect a combination of active trading and market price movements. These are descriptive metrics of fund allocation, not explicit buy or sell signals.
How do you measure hedge fund conviction and institutional concentration in IMMU?

We evaluate fund conviction by looking at portfolio weight rather than just absolute share count. By tracking how the largest holders —such as Avoro Capital Advisors , Sand Grove Capital Management , and Melqart as of Q3 2020 change their position sizing quarter-over-quarter, we help investors distinguish between deliberate position sizing changes and passive mark-to-market drift.

Does the IMMU ownership data include short interest or options?

SEC Form 13F mandates the disclosure of long positions in Section 13(f) securities, which includes equities and listed options (put and call contracts), but excludes short interest, swaps, and OTC derivatives by regulatory design. On this platform, listed options are excluded from portfolio weight calculations to ensure comparability across filers.

Are family offices and university endowments included in this IMMU data?

Yes. In addition to traditional hedge funds and large asset managers, any institutional entity exercising investment discretion over at least $100 million in Section 13(f) securities must file a Form 13F. This explicitly includes single-family offices and university endowments. If a qualifying family office or endowment holds IMMU stock, their allocation is systematically aggregated alongside traditional fund data.

When is the institutional ownership data updated, and is there a reporting lag?

Institutional investment managers are required to file their Form 13F within 45 days after the end of a calendar quarter (the standard “T+45” window). Our platform re-ingests new filings from the SEC EDGAR database on a nightly cycle, typically within 24–48 hours of publication, providing a point-in-time snapshot of reported consensus positioning for IMMU as of each filing date.